SENS Rasio Kapitalisasi marang Aset Bersih Senseonics Holdings

Simbol resmi perusahaan Senseonics Holdings (SENS)

The market trend for Senseonics Holdings (SENS), a developer of glucose monitoring systems, is based on a stable engineering staff and a partner distribution model, with the metric standing at 5.48. However, the battle for market share requires massive expenditures, which nullifies free cash flow. The situation is further complicated by logistics disruptions and sanction barriers, which significantly slow the rollout of products into foreign markets.

SENS Senseonics Holdings Inc: Nilai Pasar marang Nilai Buku ing interval 04.07.2022 - 29.10.2026
Produk asli senseonics.com

The scaling dynamics of Senseonics Holdings (SENS) within the glucose monitoring sector are reflected in the shifting ratio of market capitalization to balance sheet, which compares the current share price to net assets. This coefficient measures the market premium over equity, demonstrating investor confidence in R&D efficiency and management's ability to convert technological superiority into market share amid rising operating expenses.

Analisis pesaing

DexCom, Inc. - Rasio Nilai Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku penumbrainc.com|Novanta (NOVT) - Rasio Kapitalisasi marang Aset Bersih|Multiplikator Kapitalisasi Pasar marang Nilai Buku Haemonetics Corp|Inspire Sleep (INSP) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku Procept (PRCT)|CNMD: Rasio Kapitalisasi Pasar marang Nilai Buku|pulsebiosciences.com - Koefisien Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku InMode (INMD)|PMI - Nilai Pasar marang Nilai Buku|SRDX: Rasio Kapitalisasi Pasar marang Nilai Buku|NPCE (NeuroPace Medical) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Tactile Systems Technology, Inc. TCMD|Kapitalisasi Pasar marang Aset Bersih sanuwave.com|Outset Medical - Rasio Kapitalisasi Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku smartvest.com ELMD|Rasio Kapitalisasi marang Aset Bersih LNSR (LENSAR, Inc)|RCEL - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih Profound Medical Corporation PROF|BDMD - Multiplikator Kapitalisasi Pasar marang Nilai Buku|edap-tms.com - Rasio Kapitalisasi Pasar marang Nilai Buku|Apyx Medical Corporation (APYX) - Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku ICCM|Rasio Kapitalisasi marang Aset Bersih Pulmonx Corp. (LUNG)|TELA Bio, Inc. (TELA) - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku CTSO (cytosorbents.com)|Sensus Healthcare - Rasio Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih Zynex Medical ZYXI|ECOR (electroCore Medical) - Rasio Kapitalisasi Pasar marang Nilai Buku|RBOT - Koefisien Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku inspira-technologies.com|seastarmedical.com (ICU) - Rasio Kapitalisasi marang Nilai Buku|IRIX: Rasio Kapitalisasi Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku Intelligent Bio|Rasio Kapitalisasi Pasar marang Nilai Buku XAIR (Beyond Air, Inc.)|Rasio Kapitalisasi marang Aset Bersih Profusa, Inc (PFSA)|Rasio Kapitalisasi Pasar marang Nilai Buku SSKN (STRATA Skin Sciences, Inc.)|GlucoTrack Inc. - Rasio Kapitalisasi Pasar marang Nilai Buku|NAOV - Rasio Nilai Pasar marang Nilai Buku|Venus Concept Inc (VERO) - Rasio Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih CHF Solutions NUWE|Aethlon Medical Corp (AEMD) - Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku ASXC (Asensus Surgical Inc)|Koefisien Nilai Pasar marang Nilai Buku AVGR|BSGM: Rasio Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Ekuitas Cutera Inc. CUTR|Rasio Kapitalisasi marang Aset Bersih KNW (Know Labs Corp)|Rasio Kapitalisasi Pasar marang Nilai Buku Inari Medical Corp NARI|Rasio Kapitalisasi Pasar marang Nilai Buku NVRO (Nevro Corp.)|RSLS: Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Silk Road Medical (SILK)